Skip to main content

and
  1. Article

    Open Access

    Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial

    Most guidelines in the UK, Europe and North America do not recommend organised population-wide screening for prostate cancer. Prostate-specific antigen-based screening can reduce prostate cancer-specific morta...

    Edna Keeney, Sabina Sanghera, Richard M. Martin, Roman Gulati in PharmacoEconomics (2022)

  2. Article

    Open Access

    Challenges in Using Recommended Quality of Life Measures to Assess Fluctuating Health: A Think-Aloud Study to Understand How Recall and Timing of Assessment Influence Patient Responses

    It can be challenging to measure quality of life to calculate quality-adjusted life-years in recurrent fluctuating health states, as quality of life can constantly change. It is not clear how patients who expe...

    Sabina Sanghera, Axel Walther, Tim J. Peters in The Patient - Patient-Centered Outcomes Re… (2022)

  3. Article

    Open Access

    Measuring capability wellbeing in adults at different stages of life for use in economic evaluation of health and care interventions: a qualitative investigation in people requiring kidney care

    Capability wellbeing measures, such as the ICECAP measures, have been proposed for use in economic evaluations to capture broader outcomes of health and care interventions. The ICECAP measures have been devel...

    Paul Mark Mitchell, Samantha Husbands, Sabina Sanghera in Quality of Life Research (2021)

  4. No Access

    Article

    Response to Comment on Delphi Analysis of Relevant Comparators in a Cost-Effectiveness Model of Prostate Cancer Screening

    Edna Keeney, Howard Thom, Emma Turner, Richard M. Martin in PharmacoEconomics (2021)

  5. Article

    Open Access

    Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening

    Challenges can exist when framing the decision question in a cost-effectiveness analysis, particularly when there is disagreement among experts on relevant comparators. Using prostate cancer screening and rece...

    Edna Keeney, Howard Thom, Emma Turner, Richard M. Martin in PharmacoEconomics (2021)

  6. Article

    Open Access

    Cost-effectiveness of prostate cancer screening: a systematic review of decision-analytical models

    There is ongoing debate about the harms and benefits of a national prostate cancer screening programme. Several model-based cost-effectiveness analyses have been developed to determine whether the benefits of ...

    Sabina Sanghera, Joanna Coast, Richard M. Martin, Jenny L. Donovan in BMC Cancer (2018)

  7. Article

    Open Access

    Erratum to: Methods for evaluating medical tests and biomarkers

    Gowri Gopalakrishna, Miranda Langendam, Rob Scholten in Diagnostic and Prognostic Research (2017)

  8. Article

    Open Access

    Methods for Evaluating Medical Tests and Biomarkers

    Gowri Gopalakrishna, Miranda Langendam, Rob Scholten in Diagnostic and Prognostic Research (2017)

  9. Article

    Open Access

    Exploring the Use of Cost-Benefit Analysis to Compare Pharmaceutical Treatments for Menorrhagia

    The extra-welfarist theoretical framework tends to focus on health-related quality of life, whilst the welfarist framework captures a wider notion of well-being. EQ-5D and SF-6D are commonly used to value outc...

    Sabina Sanghera, Emma Frew, Janesh Kumar Gupta, Joe Kai in PharmacoEconomics (2015)

  10. No Access

    Article

    Adapting the CHEERS Statement for Reporting Cost-Benefit Analysis

    Sabina Sanghera, Emma Frew, Tracy Roberts in PharmacoEconomics (2015)